Skip to main content
FinSpry Logo
FinSpry
EVMN logo
EVMN
(NYSE)
Evommune, Inc.
$24.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Evommune (EVMN) Stock Price & Financial Analysis

Evommune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.31 - $24.49
52-Week High$33.20
52-Week Low$13.89
Open$22.38
Volume715.33K
Average Volume (3M)470.54K
Market Cap793.27M
Shares Outstanding33.67M
Price to Sales (P/S)79.33
Price to Book (P/B)2.60
EV/EBITDA-9.99
Revenue (TTM)10.00M
Net Income (TTM)-75.99M
Free Cash Flow (TTM)-80.36M
EPS (TTM)$-2.42
Profit Margin-759.87%
Operating Margin-899.92%
Return on Equity (ROE)-24.95%
Debt to Equity0.03
50-Day MA$23.18
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Evommune

What is the current stock price for EVMN?

As of the latest trading session, EVMN stock trades at $24.25. The 52-week range is $13.89–$33.20, with a day range of $22.31–$24.49.

What is the P/E ratio for EVMN?

The P/E ratio (Price-to-Earnings) for EVMN is shown in the Key Statistics section. This valuation metric helps compare Evommune, Inc. to industry peers.

Does EVMN pay dividends?

Evommune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EVMN?

Based on 6 analysts, the consensus for EVMN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EVMN?

Evommune's market capitalization is $816.5M, classifying it as a small-cap company. Evommune operates in the Healthcare sector within the Biotechnology industry.